Serenity and Fire with Krista
Peptides Unpacked Ep 05: The Functions, Benefits, and Science Behind Growth Hormone Peptides
Growth hormone peptides get marketed like a magic lever for muscle, fat loss, sleep, and longevity, but the real story is messier and far more interesting. I walk you through the five most discussed “growth hormone optimization” therapies and explain what each one is actually trying to do inside the body, from signaling the pituitary to nudging IGF-1 downstream. Along the way, we keep coming back to the core distinction that protects you from hype: changing a lab number is a mechanism, not a guarantee of a better clinical outcome. We start with CJC-1295 and the GHRH pathway, then unpack why “DAC” matters, how albumin binding extends half-life, and why longer-lasting isn’t automatically better when your body naturally runs on hormone pulses. From there, we move into Ipamorelin and the ghrelin receptor, why clinicians pair it with CJC-1295, and what we still don’t know from long-term randomized human trials. I also explain where Sermorelin fits as a more established, shorter-acting option with a long clinical track record. Then we talk about the outliers with the biggest misconceptions. Tesamorelin is FDA-approved, but only for a specific condition: excess visceral abdominal fat in HIV-associated lipodystrophy. That approval tells us something real about evidence, and also what it does not prove for general anti-aging. Finally, we break down MK-677 (Ibutamoren), why it’s grouped with peptides even though it isn’t a peptide, what the research suggests about lean body mass and sleep, and why appetite and glucose effects can be deal-breakers for some people. If you want a grounded, evidence-informed way to think about growth hormone peptides, hit subscribe, share the show with a friend, and leave a review so more people can find it.
